SCHEMBL30797016

SCHEMBL30797016

O=C(OCc1ccccc1)N1CCN(c2cccc3c2CCN3)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 3/20 0.57
SIGMAR1 Q99720 3/20 0.57
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HTR1A P08908 1/20 0.47
DRD2 P14416 1/20 0.47
CXCR3 P49682 3/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 2/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46
F2 P00734 2/20 0.45
F12 P00748 2/20 0.45
SLC29A1 Q99808 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL26101391 0.94 TMEM97 (0.52) TMEM97SIGMAR1MEN1KMT2ANPSR1
SCHEMBL13996370 0.79 MAPK1 (0.53) MAPK1ALDH1A1MAPT
SCHEMBL973529 0.78 MEN1 (0.49) TMEM97SIGMAR1MEN1KMT2ANPSR1
SCHEMBL31600827 0.77 TMEM97 (0.45) TMEM97SIGMAR1MEN1KMT2ANPSR1
SCHEMBL5362589 0.77 SMN1; SMN2 (0.72) TMEM97SIGMAR1MEN1KMT2ANPSR1
SCHEMBL26098701 0.76 AVPR1A (0.38) HTR1ADRD2SMN1; SMN2GAAMAPK1
SCHEMBL3970912 0.76 MEN1 (0.76) MEN1KMT2ANPSR1SMN1; SMN2NPC1
SCHEMBL4814264 0.76 MEN1 (0.76) MEN1KMT2ANPSR1SMN1; SMN2NPC1
SCHEMBL379160 0.76 MEN1 (0.76) MEN1KMT2ANPSR1SMN1; SMN2NPC1
SCHEMBL7393652 0.76 MEN1 (0.76) MEN1KMT2ANPSR1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4539849-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 Therapeutics, Inc. (US) 2025-04-23 EP disclosed
WO-2023244764-A1 COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 C4 THERAPEUTICS, INC. (US) 2023-12-21 WO disclosed